Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Eur Urol Oncol. 2019 Jun 14;2(6):605–616. doi: 10.1016/j.euo.2019.05.004

Fig. 2 −.

Fig. 2 −

Forest plots of relative detection rate of clinically significant, clinically insignificant, and any prostate cancer in the MRI-stratified pathway and the systematic TRUS-guided biopsy pathway. A relative detection rate of >1 indicates that the MRI-stratified pathway detects more cancers, while a rate of <1 means that the MRI-stratified pathway detects fewer cancers than the systematic TRUS-guided biopsy pathway. Bx = biopsy; CI = confidence interval; MRI = magnetic resonance imaging; RR = risk ratio; TRUS = transrectal ultrasound.